Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Draths launched with $1M for avian influenza drug development
May 18th, 2006
The spread of Avian flu continues to be a worldwide concern, especially with the limited resources available to manufacture the key anti-influenza drug Tamiflu and the potential of genetic resistance among new viral strains. Brad Greenspan, entrepreneur and investor, announced a $1 million investment which has seed funded and launched the Draths Corp., a "green" bio-based chemical manufacturing company which aims to make the key building block in the production of Tamiflu available and also develop new anti-influenza drug candidates built on higher-yield, more cost effective syntheses. The company's cofounders, John Frost, Karen Draths and Mark...
Source: Biotech Business Week (2006-05-18)
|
